Objective: To evaluate the efficacy of cytoflavin in the treatment of hypoxic-ischemic lesions of the nervous system in young infants with transient neonatal hypothyroidism.
Material And Methods: Authors analyzed the efficacy of cytoflavin in the treatment of cerebral ischemia in the combination with transient neonatal hypothyroidism in 89 newborns. The main group comprised 43 children treated with intravenous cytoflavin in dose 2 ml per 1 kg of body weight per day for five days; 46 newborns of the comparison group received basic therapy.